D.E. Shaw & Co’s Cascadian Therapeutics, Inc. CASC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q1 | – | Sell |
-16,846
| Closed | -$62K | – | 2762 |
|
|
2017
Q4 | $62K | Buy |
16,846
+2,400
| +17% | +$8.83K | ﹤0.01% | 2474 |
|
|
2017
Q3 | $59K | Sell |
14,446
-2,516
| -15% | -$10.3K | ﹤0.01% | 2431 |
|
|
2017
Q2 | $63K | Sell |
16,962
-49,697
| -75% | -$185K | ﹤0.01% | 2350 |
|
|
2017
Q1 | $276K | Buy |
66,659
+53,696
| +414% | +$222K | ﹤0.01% | 2190 |
|
|
2016
Q4 | $56K | Sell |
12,963
-4
| -0% | -$17 | ﹤0.01% | 2436 |
|
|
2016
Q3 | $128K | Sell |
12,967
-1,820
| -12% | -$18K | ﹤0.01% | 2392 |
|
|
2016
Q2 | $83K | Sell |
14,787
-6,539
| -31% | -$36.7K | ﹤0.01% | 2462 |
|
|
2016
Q1 | $163K | Sell |
21,326
-32,896
| -61% | -$251K | ﹤0.01% | 2426 |
|
|
2015
Q4 | $722K | Sell |
54,222
-12,507
| -19% | -$167K | ﹤0.01% | 1915 |
|
|
2015
Q3 | $1.1M | Sell |
66,729
-24,119
| -27% | -$397K | ﹤0.01% | 1681 |
|
|
2015
Q2 | $2.04M | Sell |
90,848
-105,676
| -54% | -$2.37M | ﹤0.01% | 1489 |
|
|
2015
Q1 | $1.92M | Buy |
196,524
+40,449
| +26% | +$396K | ﹤0.01% | 1393 |
|
|
2014
Q4 | $1.78M | Buy |
156,075
+16,969
| +12% | +$193K | ﹤0.01% | 1408 |
|
|
2014
Q3 | $1.6M | Sell |
139,106
-26,211
| -16% | -$302K | ﹤0.01% | 1331 |
|
|
2014
Q2 | $3.21M | Buy |
165,317
+44,315
| +37% | +$862K | ﹤0.01% | 1070 |
|
|
2014
Q1 | $2.17M | Buy |
121,002
+30,949
| +34% | +$555K | ﹤0.01% | 1221 |
|
|
2013
Q4 | $951K | Buy |
90,053
+6,838
| +8% | +$72.2K | ﹤0.01% | 1656 |
|
|
2013
Q3 | $1.03M | Buy |
83,215
+15,835
| +24% | +$196K | ﹤0.01% | 1555 |
|
|
2013
Q2 | $630K | Buy |
+67,380
| New | +$630K | ﹤0.01% | 1728 |
|